NVCR- Novocure Limited

Name: Novocure Limited Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Cordova Ashley	437.6K	$6.59M	-
Dir	Danziger Asaf	416.5K	$6.27M	-
VP	Leonard Frank X	347.7K	$5.23M	-
Other	Ben Arye Barak	174.5K	$2.63M	-
Other	Puri Michal Nath	163.8K	$2.46M	-

Activity

Buys and sells only

Transactions

10 filings · page 34

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jan 11, 2018	Kirson Eilon D.	Chief Science Officer	Sell	25,320	$22.00	$557,126.09	-88.8%
Jan 9, 2018	Groenhuysen Wilhelmus Cm65	Chief Financial Officer	Sell	31,132	$21.02	$654,375.96	-13.0%
Jan 4, 2018	Groenhuysen Wilhelmus Cm65	Chief Financial Officer	Sell	28,868	$21.03	$607,002.54	-3.6%
Nov 13, 2017	Palti Yoram	Chief Technology Officer	Sell	30,000	$17.13	$513,870.00	-2.1%
Nov 10, 2017	Palti Yoram	Chief Technology Officer	Sell	90,000	$18.49	$1,663,831.66	-1.0%
Nov 7, 2017	Palti Yoram	Chief Technology Officer	Sell	60,000	$21.06	$1,263,760.00	-1.3%
Nov 6, 2017	Kirson Eilon D.	Chief Science Officer	Sell	9,100	$22.00	$200,200.00	-24.2%
Nov 6, 2017	Danziger Asaf61	Chief Executive Officer	Sell	6,919	$22.00	$152,218.00	-0.9%
Nov 3, 2017	Danziger Asaf61	Chief Executive Officer	Sell	2,300	$22.00	$50,600.00	-0.3%
Nov 3, 2017	Ambrogi Michael J.	Chief Operating Officer	Sell	1,200	$22.00	$26,400.00	-2.4%

← PrevPage 34Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC